Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taroh Satoh

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2015
[First-line chemotherapy for unresectable and metastatic colorectal cancer]Taroh Satoh
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Chemotherapy for gastrointestinal cancer patients in elderly]Taroh Satoh
Gastrointestinal Cancer Research : GCR|May 23, 2009
On the path to standardizing esophageal cancer treatment in JapanTaroh Satoh, Yuh Sakata
Expert Opinion on Pharmacotherapy|August 7, 2012
S-1 for the treatment of gastrointestinal cancerTaroh Satoh, Yuh Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer]Hisato Kawakami, Taroh Satoh, Kazuhiko Nakagawa
International Journal of Clinical Oncology|May 11, 2024
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancerNaohiro Nishida, Daisuke Sakai, Taroh Satoh
Investigational New Drugs|June 3, 2011
Reversible posterior leukoencephalopathy syndrome and trastuzumabHiroyasu Kaneda, Isamu Okamoto, Taroh Satoh, et al.
The Oncologist|April 19, 2015
A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomasShinya Ueda, Taroh Satoh, Masahiro Gotoh, et al.
Japanese Journal of Clinical Oncology|November 11, 2020
Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation studyToshihiro Kudo, Yoshiyuki Murai, Yoshitsugu Kojima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitisHisato Kawakami, Koji Sugioka, Kimio Yonesaka, et al.
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2015
[First-line chemotherapy for unresectable and metastatic colorectal cancer]Taroh Satoh
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Chemotherapy for gastrointestinal cancer patients in elderly]Taroh Satoh
Gastrointestinal Cancer Research : GCR|May 23, 2009
On the path to standardizing esophageal cancer treatment in JapanTaroh Satoh, Yuh Sakata
Expert Opinion on Pharmacotherapy|August 7, 2012
S-1 for the treatment of gastrointestinal cancerTaroh Satoh, Yuh Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer]Hisato Kawakami, Taroh Satoh, Kazuhiko Nakagawa
International Journal of Clinical Oncology|May 11, 2024
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancerNaohiro Nishida, Daisuke Sakai, Taroh Satoh
Investigational New Drugs|June 3, 2011
Reversible posterior leukoencephalopathy syndrome and trastuzumabHiroyasu Kaneda, Isamu Okamoto, Taroh Satoh, et al.
The Oncologist|April 19, 2015
A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomasShinya Ueda, Taroh Satoh, Masahiro Gotoh, et al.
Japanese Journal of Clinical Oncology|November 11, 2020
Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation studyToshihiro Kudo, Yoshiyuki Murai, Yoshitsugu Kojima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitisHisato Kawakami, Koji Sugioka, Kimio Yonesaka, et al.
Pageof 28